ubenimex has been researched along with curcumin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhikari, N; Amin, SA; Jha, T | 1 |
| Cho, HY; Choi, SH; Kim, JH; Kim, SH; Kwon, HJ; Park, HJ; Shim, BS; Shim, JS; Yum, YN | 1 |
| Bauvois, B; Dauzonne, D | 1 |
2 review(s) available for ubenimex and curcumin
| Article | Year |
|---|---|
Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
Topics: Antineoplastic Agents; CD13 Antigens; Drug Design; Humans; Molecular Targeted Therapy; Protease Inhibitors | 2018 |
Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Topics: Animals; Betulinic Acid; CD13 Antigens; Cell Proliferation; Curcumin; Disulfides; Humans; Hydroxamic Acids; Leucine; Neovascularization, Physiologic; Neprilysin; Oligopeptides; Pentacyclic Triterpenes; Protease Inhibitors; Triterpenes; Tyrosine | 2006 |
1 other study(ies) available for ubenimex and curcumin
| Article | Year |
|---|---|
Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; CD13 Antigens; Cell Line; Cell Line, Tumor; Curcumin; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Humans; Kinetics; Leucine; Molecular Structure | 2003 |